Edan Instruments, Inc.

Shenzhen Stock Exchange 300206.SZ

Edan Instruments, Inc. Debt to Equity Ratio for the year ending December 31, 2023: 0.01

Edan Instruments, Inc. Debt to Equity Ratio is 0.01 for the year ending December 31, 2023, a 0.55% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Edan Instruments, Inc. Debt to Equity Ratio for the year ending December 31, 2022 was 0.01, a -86.81% change year over year.
  • Edan Instruments, Inc. Debt to Equity Ratio for the year ending December 31, 2021 was 0.04, a -22.81% change year over year.
  • Edan Instruments, Inc. Debt to Equity Ratio for the year ending December 31, 2020 was 0.06, a 0.00% change year over year.
  • Edan Instruments, Inc. Debt to Equity Ratio for the year ending December 31, 2019 was 0.00, a 0.00% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 300206.SZ

Edan Instruments, Inc.

CEO Mr. Hao Zhang
IPO Date April 21, 2011
Location China
Headquarters Jinsha Community
Employees 2,695
Sector Healthcare
Industries
Description

Edan Instruments, Inc. engages in the research, development, manufacture, and sale of medical equipment worldwide. The company offers diagnostic electrocardiograph (ECG) products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as vital signs, transport, and central monitoring systems, as well as high acuity cares, acute and sub-acute cares, telemetry, and pulse oximetry products; and obstetrics and gynecology products comprising fetal and maternal monitoring systems, fetal telemetry systems, ultrasonic doppler systems, and video colposcopes. It also provides ultrasound imaging systems that include color doppler ultrasound and B/W digital ultrasound systems; and in-vitro diagnostics, which comprise hematology analyzers. In addition, the company offers point-of-care testing systems, including blood gas and chemistry, magnetic immunoassay, and colloidal gold-labeled immunoassay analyzers; and veterinary ultrasound, ECG, ABG, and monitoring products. Edan Instruments, Inc. is headquartered in Shenzhen, the People's Republic of China.

Similar companies

300244.SZ

Dian Diagnostics Group Co.,Ltd.

USD 1.44

-2.25%

300298.SZ

Sinocare Inc.

USD 3.08

-1.16%

300326.SZ

Shanghai Kinetic Medical Co., Ltd

USD 0.98

1.04%

002223.SZ

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

USD 4.94

2.25%

300246.SZ

Guangdong Biolight Meditech Co., Ltd.

USD 0.89

-0.40%

StockViz Staff

February 2, 2025

Any question? Send us an email